Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as GBX 5 ($0.06) and last traded at GBX 4.70 ($0.06), with a volume of 157404 shares changing hands. The stock had previously closed at GBX 4.45 ($0.05).
Proteome Sciences Price Performance
The business has a 50-day simple moving average of GBX 3.20 and a 200 day simple moving average of GBX 3.14. The firm has a market cap of £13.86 million, a PE ratio of -469.50 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- What is Insider Trading? What You Can Learn from Insider Trading
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Buy P&G Now, Before It Sets A New All-Time High
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- The How and Why of Investing in Gold Stocks
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
